These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4686221)

  • 1. [Primary hyperaldosteronism with malignant hypertension].
    Baglin A; Weiss Y; Safar M; Milliez P
    Nouv Presse Med; 1973 Feb; 2(5):295-7. PubMed ID: 4686221
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhabdomyolysis due to primary hyperaldosteronism.
    Martínez JJ; Oliveira CL; Meneses AL; Rodríguez SA; Corrales PP; López AH; Romero FB
    Endocrinol Nutr; 2009 Oct; 56(8):431-4. PubMed ID: 19959155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary adlosteronism with malignant hypertension].
    Sasano N; Saito K; Wagai K; Kijima M; Koga K
    Shujutsu; 1968 Aug; 22(8):836-40. PubMed ID: 5703165
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
    Biglieri EG; Kater CE; Arteaga EE
    J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endocrinologic and circulatory findings in a case of primary aldosteronism].
    Marsen B; Dissmann T; Oelkers W; Lohmann FW; Molzahn M; Gotzen R
    Dtsch Med Wochenschr; 1971 May; 96(22):951-4. PubMed ID: 5578596
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of plasma renin concentration by angiotensin I immunoassay. Diagnotic import of precise measurement of subnormal renin in hyperaldosteronism.
    Stockigt JR; Collins RD; Biglieri EG
    Circ Res; 1971 May; 28(5):Suppl 2:175-91. PubMed ID: 4327961
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of glucocorticoid-suppressible hyperaldosteronism with aldosterone producing adenoma.
    Kato S; Haji M; Yanase T; Nawata H; Kato K; Ibayashi H
    Endocrinol Jpn; 1988 Apr; 35(2):311-20. PubMed ID: 3208706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conn's syndrome can cause malignant hypertension.
    Sunman W; Rothwell M; Sever PS
    J Hum Hypertens; 1992 Feb; 6(1):75-6. PubMed ID: 1583635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How?].
    Herpin D; Sosner P; Amar J; Chamontin B
    Arch Mal Coeur Vaiss; 2003 Jan; 96(1):37-42. PubMed ID: 12613148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypokalemia with normal blood pressure preceding malignant hypertension in a patient with primary aldosteronism (Conn's syndrome).
    Velasquez MT; Saini N; Cohn JN
    Med Ann Dist Columbia; 1972 Dec; 41(12):732-5. PubMed ID: 4509127
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary aldosteronism.
    Biglieri EG
    Curr Ther Endocrinol Metab; 1994; 5():152-5. PubMed ID: 7704703
    [No Abstract]   [Full Text] [Related]  

  • 14. [A description of a case of Conn's syndrome (author's transl)].
    Martin PL; Dallocchio M; Fourcade JP; Clémenty J; Coqueran J; Choussat A; Bricaud H
    J Radiol Electrol Med Nucl; 1974 May; 55(5):419-22. PubMed ID: 4408421
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of plasma renin in arterial hypertension with corticoadrenal adenoma. Conn's syndrome].
    Meyer P; Ménard J; Alexandre JM; Druet P; Milliez P
    Prensa Med Argent; 1966; 53(9):710-7. PubMed ID: 6003000
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of hypertensive patients.
    Wilkins RW; Hollander W; Chobanian AV
    Clin Symp; 1972; 24(2):5-30. PubMed ID: 4556614
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant hypertension due to an aldosterone producing adrenal adenoma.
    Murphy BF; Whitworth JA; Kincaid-Smith P
    Clin Exp Hypertens A; 1985; 7(7):939-50. PubMed ID: 3899416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperaldosteronism in a patient with end-stage renal disease.
    Kazory A; Weiner ID
    Nephrol Dial Transplant; 2007 Mar; 22(3):917-9. PubMed ID: 17127694
    [No Abstract]   [Full Text] [Related]  

  • 19. Unilateral adrenalectomy for aldosteronomas localized preoperatively by differential adrenal vein catheterization.
    Egdahl RH; Kahn PC; Melby JC
    Surgery; 1968 Jul; 64(1):117-25. PubMed ID: 5658720
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism.
    Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI; Tree M
    Q J Med; 1976 Jul; 45(179):401-10. PubMed ID: 948542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.